Repository logo
 

NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo

Published version
Peer-reviewed

Change log

Authors

Di Stefano, M 
Orsomando, G 
Mori, V 
Zamporlini, F 

Abstract

Axons require the axonal NAD-synthesizing enzyme NMNAT2 to survive. Injury or genetically induced depletion of NMNAT2 triggers axonal degeneration or defective axon growth. We have previously proposed that axonal NMNAT2 primarily promotes axon survival by maintaining low levels of its substrate NMN rather than generating NAD; however, this is still debated. NMN deamidase, a bacterial enzyme, shares NMN-consuming activity with NMNAT2, but not NAD-synthesizing activity, and it delays axon degeneration in primary neuronal cultures. Here we show that NMN deamidase can also delay axon degeneration in zebrafish larvae and in transgenic mice. Like overexpressed NMNATs, NMN deamidase reduces NMN accumulation in injured mouse sciatic nerves and preserves some axons for up to three weeks, even when expressed at a low level. Remarkably, NMN deamidase also rescues axonal outgrowth and perinatal lethality in a dose-dependent manner in mice lacking NMNAT2. These data further support a pro-degenerative effect of accumulating NMN in axons in vivo. The NMN deamidase mouse will be an important tool to further probe the mechanisms underlying Wallerian degeneration and its prevention.

Description

Keywords

NAD, NMN, NMN deamidase, NMNAT, NMNAT2, SARM1, WLD$^\text{s}$, Wallerian degeneration, axon degeneration, neurodegeneration

Journal Title

Current Biology

Conference Name

Journal ISSN

0960-9822
1879-0445

Volume Title

27

Publisher

Elsevier (Cell Press)
Sponsorship
Medical Research Council (MR/N004582/1)
Parkinson's UK (G-1602)
We thank Tim Self, Denise McLean, Ian Ward, and CSI/SLIM for use of imaging facilities and help with tissue processing. This work was funded by a Faculty of Medicine and Health Sciences, University of Nottingham nonclinical senior fellowship (to L.C.); a Marie Curie Intra European Fellowship (project number 301897) within the European Community 7th Framework Programme (to M.D.S. and L.C.); and an Institute Strategic Programme Grant from the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) grant MR/N004582/1 (to J.G. and M.P.C.).